A few words about the Pharmaceutical Industry

Certainly, the covid pandemic was an historic moment when the Pharmaceutical industry secured a preeminent place in global headlines. Disruption, restructuring, and transformation continue to be the foundations of the industry’s future. Acceleration in the way vaccines are developed and delivered, increasing digitalization of manufacturing systems, AI, precision medicines, new cures, new demographic trends having access to medicine, and countless other issues are both risks and opportunities. While change is nothing new to an industry driven by R&D, change of this magnitude is complex to absorb within a highly regulated landscape, and the need for structured analytical processes has never been greater.

Kepner-Tregoe works with pharmaceutical companies worldwide to improve transformation agility, troubleshooting capabilities, and compliance systems within all relevant ecosystems. We work with organizations to improve the speed and quality of investigations as well as corrective and preventive measure implementation. Our approach to documented root cause analysis is globally recognized for improving the precision and speed of issue resolution, the CAPA process, and the regulatory compliant documentation of results. Our consulting and capability development programs build confidence in critical thinking skills which in turn translate into a strategic competitive advantage for our clients.

The Kepner-Tregoe methodologies utilize analytical data effectively in order to solve problems and make decisions quickly—and bring transparency to the process. The institutional adoption of our structured processes to call critical functions within client organizations brings sustainable and measurable results. Structured, advanced critical thinking approaches to problem solving and decision making are used and applied across help desks, in logistics and finance functions, and in the executive suites of our pharmaceutical clients.

To learn more about Kepner-Tregoe consulting and training solutions for the Pharmaceutical industry, contact Kepner-Tregoe.

成功案例

挑战

Novartis was developing a new process that was among the most complex ever introduced at NRL in terms of chemistry and equipment. Added to this was a crushing schedule. It takes several weeks to produce the API used in this drug. When the first batch was completed, the quality was to spec but the quantity was below target yield. The yield problem had to be fixed quickly in order to ensure supply to links further up the chain.

20%

Increased sales

结果

Sharing a strong commitment to resolving the yield problem, the team followed the KT’s ATS process using data from a variety of sources including manual and electronic batch records and trends, development reports, and production shift logs. The problem was solved, and “fixes” were made. When the first fixed batch was completed several weeks later, it met standard yield. Validation was completed in record time. Novartis beat the competition to market, increased market share, and sales boomed, increasing 20%.

挑战

Gerresheimer, manufactures specialty glass and plastic products that support the highly regulated pharmaceutical and healthcare industries. Issues arose as the result of a material change-a component made of a soft plastic material had to be changed to a comparable material when the existing one was no longer available.

€100K+

Saved

结果

The application of KT process yielded significant results beyond the hundreds of thousands of euros saved when the quarantined batches were released and shipped to the customer. Most importantly, product safety was ensured. The use of KT analysis and the confirmed root cause helped Gerresheimer to eliminate any risk to end-use customers and avoided the potential for recalls of product already on the market.

挑战

一家全球生物制药公司的现场管理人员探讨了减少调查数量以及结束调查所需天数的机会。该工厂没有一个标准的、系统的方法来寻找制造偏差的根本原因。

33%

减少所需的调查

13%

与前一年相比,成交量下降到这个水平

结果

改进调查程序并将KT作为调查方法的工作计划在不到6个月的时间内完全制定并实施。

洞察力

纠正和预防措施(CAPA)在不断发展。持续改进的CAPA

用只解决短期问题的CAPA来应对审计和产品召回的做法已不再被接受。现在,所有这些都是为了使CAPA和持续改进过程保持一致。

超越合规性。利用cGMP的合规性来提高业务成果

Customer complaints can be a significant source of information to control costs and actually enhance customer satisfaction. Using case studies and examples, the author demonstrates how a systematic approach to customer service can improve business results.

Reducing Human Error in Life Sciences Manufacturing: 5 Opportunities for Improvement

When human error is to blame, corrective actions often involve addressing the system itself—its balance of consequences, feedback mechanisms, targets and objectives. Consider five factors that influence human error and offer opportunities for improvement.

Kepner-Tregoe Tools and Process Validation

Controlling process change can be improved, KT methods support three key areas of process validation: planning, installation and qualification

褒奖

我们的专家
in Pharmaceutical Industry

约翰-艾格
商业解决方案顾问
北美
Erika Ratcliffe
业务解决方案高级顾问
欧洲
Amelia Lim
商业解决方案顾问
亚洲
上杉隆司
业务解决方案高级顾问
日本

联系我们

如需咨询、了解详情,或提出建议!